Efficacy of tissue plasminogen activator administration on patency of hemodialysis access catheters

Nonparametric Estimation from Incomplete Observations

Edward L. Kaplan, Paul Meier · Journal of the American Statistical Association · 1958 · 39.1K citations

Public Health, Biostatistics, Mathematics +10

Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology.

Frans Van de Werf, Steven R. Bergmann, Keith A.A. Fox et al. · Circulation · 1984 · 179 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

Urokinase versus Recombinant Tissue Plasminogen Activator in Thrombosed Central Venous Catheters:

William D. Haire, James B Atkinsonn, L. Clifton Stephens et al. · Thrombosis and Haemostasis · 1994 · 138 citations

Medicine, Pharmacology, Pharmacotherapy +13

Barriers to adequate delivery of hemodialysis

AR Sehgal, R. B. Snow, Mendel E. Singer et al. · American Journal of Kidney Diseases · 1998 · 95 citations

Medicine, Internal Medicine, Nephrology +10

Investigational Use of Tissue Plasminogen Activator (t‐PA) for Occluded Central Venous Catheters

James B. Atkinson, Holly A. Bagnall, Edward D. Gomperts · Journal of Parenteral and Enteral Nutrition · 1990 · 78 citations

Medicine, Pharmacotherapy, Cardiovascular Pharmacotherapy +9